Growth of Healthy Term Infants Fed a Partially Hydrolyzed Follow-up Formula
Effect of a New Formula With a Reduced Concentration of Partially Hydrolyzed Protein on Growth of Healthy Term Infants: an Open-label Study
Sponsor: Biofortis Mérieux NutriSciences
This NA trial investigates Growth and is currently completed. Biofortis Mérieux NutriSciences leads this study, which shows 14 recorded versions since 2017 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Mar 2023 — Jul 2024 [monthly]
Completed NA
-
Jan 2021 — Mar 2023 [monthly]
Completed NA
-
Aug 2020 — Jan 2021 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
▶ Show 9 earlier versions
-
Feb 2020 — Aug 2020 [monthly]
Active Not Recruiting NA
-
Sep 2019 — Feb 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2019 — Sep 2019 [monthly]
Recruiting NA
-
Mar 2019 — Jun 2019 [monthly]
Recruiting NA
-
Jan 2019 — Mar 2019 [monthly]
Recruiting NA
-
Jun 2018 — Jan 2019 [monthly]
Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Recruiting NA
-
Dec 2017 — Apr 2018 [monthly]
Recruiting NA
Status: Active Not Recruiting → Recruiting
-
Oct 2017 — Dec 2017 [monthly]
Active Not Recruiting NA
First recorded
Sep 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Biofortis Mérieux NutriSciences
- Société des Produits Nestlé (SPN)
For direct contact, visit the study record on ClinicalTrials.gov .